Home > Compound List > Product Information
Floxuridine_Molecular_structure_CAS_50-91-9)
Click picture or here to close

Floxuridine

Catalog No. DB00322 Name DrugBank
CAS Number 50-91-9 Website http://www.ualberta.ca/
M. F. C9H11FN2O5 Telephone (780) 492-3111
M. W. 246.1924432 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 207

SYNONYMS

IUPAC name
5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
IUPAC Traditional name
floxuridine
Brand Name
FUDR
Synonyms
Fluorodeoxyuridine
Deoxyfluorouridine
Floxiridina [INN-Spanish]
5 Fluorodeoxyuridine
5FDU
FDUR
FDURD
Floxuridinum [INN-Latin]
Floxuridin
Fluoruridine Deoxyribose

DATABASE IDS

PubChem CID 5790
PubChem SID 46508645
CAS Number 50-91-9

PROPERTIES

Hydrophobicity(logP) -1.4
Solubility 1.19E+004 mg/L

DETAILS

Description (English)
Item Information
Drug Groups approved
Description An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection. Floxuridine is available as a sterile, nonpyrogenic, lyophilized powder for reconstitution. When administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. [PubChem]
Indication For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. Also for the palliative management of liver cancer (usually administered by hepatic intra-arterial infusion).
Pharmacology Floxuridine is a pyrimidine analog that acts as an inhibitor of the S-phase of cell division. This selectively kills rapidly dividing cells. Floxuridine is an anti-metabolite. Anti-metabolites masquerade as pyramidine-like molecules which prevents normal pyrimidines from being incorporated into DNA during the S phase of the cell cycle. Flurouracil (the end-product of catabolism of floxuridine) blocks an enzyme which converts cytosine nucleosides into the deoxy derivative. In addition, DNA synthesis is further inhibited because fluoruracil blocks the incorporation of the thymdine nucleotide into the DNA strand.
Toxicity Oral, rat LD50: 215 mg/kg. Signs of overdose include nausea, vomiting, diarrhea, gastrointestinal ulceration and bleeding, and bone marrow depression (including thrombocytopenia, leukopenia and agranulocytosis).
Affected Organisms
Humans and other mammals
Biotransformation Hepatic.
Elimination The drug is excreted intact and as urea, fluorouracil, a-fluoro-bureidopropionic acid, dihydrofluorouracil, a-fluoro-b-guanidopropionic acid and a-fluoro-b-alanine in the urine; it is also expired as respiratory carbon dioxide.
External Links
Wikipedia
RxList
Drugs.com

REFERENCES